Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder

NCT00514865 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

278

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: ONO-2333Ms Experimental 2
DRUG: Placebo
DRUG: ONO-2333Ms Experimental 1

Sponsor

Ono Pharma USA Inc